Figure 1From: Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction Kaplan Meier overall survival (A) and progression-free survival (B) in dose levels 1–3. Back to article page